Benadryl (diphenhydramine), a first-generation H1 antihistamine, has limited direct efficacy in treating cluster headaches. While its primary mechanism involves antagonizing histamine receptors, its potential benefit in cluster headache management may be related to its sedative properties and ability to modulate neuroinflammatory processes, though robust clinical evidence supporting its use is limited.